anti-Butyrophilin-Like 2 (MHC Class II Associated) (BTNL2) Antibodies

Negative regulator of T-cell proliferation.. Additionally we are shipping BTNL2 Proteins (8) and BTNL2 Kits (6) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
BTNL2 56244 Q9UIR0
BTNL2 309620  
BTNL2 547431 O70355
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online

Top anti-BTNL2 Antibodies at

Showing 10 out of 21 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Human Rabbit Un-conjugated IF (p), IHC (p) Formalin-fixed and paraffin embedded human kidney labeled with Anti-BTNL2 Polyclonal Antibody, Unconjugated (ABIN1386835) at 1:200 followed by conjugation to the secondary antibody and DAB staining 100 μL Log in to see 3 to 7 Days
Human Rabbit Un-conjugated IHC, WB Western blot analysis of extracts of various cell lines, using BTNL2 antibody. 100 μL Log in to see 11 to 13 Days
Human Rabbit Un-conjugated IHC, WB   50 μL Log in to see 11 to 14 Days
Human Rabbit Un-conjugated WB 100 μL Log in to see 11 to 18 Days
Human Rabbit Un-conjugated WB Western blot analysis of extracts of various cell lines, using BTNL2 antibody (ABIN5975278) at 1/1000 dilution. 100 μL Log in to see 11 to 16 Days
Human Rabbit Un-conjugated WB   50 μL Log in to see 11 to 13 Days
Human Rabbit HRP ELISA   100 μg Log in to see 11 to 16 Days
Human Rabbit Biotin ELISA   100 μg Log in to see 11 to 16 Days
Human Rabbit FITC ELISA   100 μg Log in to see 11 to 16 Days
Human Rabbit Un-conjugated ELISA, IHC, WB   100 μg Log in to see 11 to 16 Days

More Antibodies against BTNL2 Interaction Partners

Human Butyrophilin-Like 2 (MHC Class II Associated) (BTNL2) interaction partners

  1. Host-genotype analysis revealed an association of the rs2076530 (BTNL2) risk allele with a decrease in bacterial burden in sarcoidosis.

  2. HLA-DPB1*05:01 gene was associated with the geographical region of PV and the BTNL2 gene was significantly associated with family history and age of onset of PV. In conclusion, the HLA-DPB1*05:01 and BTNL2 genes might be responsible for the complicacy of clinical features.

  3. The sarcoidosis risk variant BTNL2 c.1078G.A (rs2076530) was associated with disease in all OFG cases (P (1/4) 0.013; OR (1/4) 1.33; 95% CI, 1.06-1.67) and had a similar OR (1.56) and the same direction of effect as seen in sarcoidosis. However, no association was seen for the subphenotypes of OFG only or OFG+CD.

  4. Despite a significant difference in BTNL2 polymorphism between sarcoid patients and controls, there was no such difference between familial and sporadic sarcoidosis cases and no correlation between BTNL2 polymorphism and disease severity or outcome. Thus, BTNL2 difference cannot be considered as a key marker for disease classification or patient management.

  5. Two new signals were observed at genome-wide significance (P < 5 x 10-8), namely, rs7216064 (17q24.3, BPTF), for overall lung adenocarcinoma risk, and rs3817963 (6p21.3, BTNL2) which is specific to cases with EGFR mutations. In further sub-analyses by EGFR status, rs9387478 (ROS1/DCBLD1) and rs2179920 (HLA-DPB1) showed stronger estimated associations in EGFR-positive compared to EGFR-negative cases

  6. BTNL2 variant is associated with psoriasis.

  7. Butyrophilin-like 2, expressed at various levels by UM cells and macrophages, might interfere with the immune control of the tumor. Butyrophilin-like 2 variants showed highly variable frequencies among ethnically related cohorts. There was no enrichment of BTNL2 variants in patients with UM compared with control patients.

  8. BTNL2 G16071A gene polymorphism may as a likelihood factor contributed to granulomatous disease susceptibility, especially increasing the sarcoidosis susceptibility. In addition, the polymorphism may be greatly associated with likelihood of granulomatous diseases among Caucasians.

  9. BTNL2 may have an inhibitory effect on FOXP3(+) T cell proliferation, especially in patients homozygous for the risk alleles.

  10. genetic mutations within or around BTNL2 (rs3763313, rs9268494, rs9268492 and rs9268402) could alter susceptibility to grade IV of dilated cardiomyopathy in a Chinese population

  11. Results confirm the association of BTNL2 rs2076530SNP with the susceptibility to develop sarcoidosis, but not with an increased risk of cancer in these patients.

  12. BTNL2 rs2076530 polymorphism contributes to the risk of sarcoidosis

  13. Two independent loci near BTNL2 (rs9461741) and HLA-B (rs2922994) in the HLA region significantly associated with Marginal Zone B-Cell Lymphoma risk.

  14. The association of the rare variant p.G454C in BTNL2 reached genome-wide significance, and was independent of the known common risk variants for IBD in the HLA region in both a conditional and haplotype analysis

  15. These findings suggest that polymorphisms in the BTNL2 gene might play a vital role in determining the outcome of the immune response to hepatitis B vaccination.

  16. No variation except in the 329-bp region containing the BTNL2 rs2076530 polymorphism was found in Turkish patients with sarcoidosis.

  17. Rare BTNL2 variants play a role in susceptibility to both familial and sporadic prostate cancer. Results implicate BTNL2 as a novel prostate cancer susceptibility gene.

  18. the BTNL2 splice site polymorphism (A variant of rs2076530) shows association with an increased risk for persistent sarcoidosis

  19. sequenced single-nucleotide variants in an association study of 432 cases and 432 controls showed that 12 non-synonymous single-nucleotide polymorphisms (SNPs) in BTNL2 were significantly associated with RA

  20. Results show that single nucleotide polymorphism associated with BTNL2 gene is a risk factor for predisposition pulmonary sarcoidosis

Mouse (Murine) Butyrophilin-Like 2 (MHC Class II Associated) (BTNL2) interaction partners

  1. Butyrophilin-like 2 modulates B7 costimulation to induce Foxp3 expression and regulatory T cell development in mature T cells.

  2. BTNL2 is overexpressed during both the asymptomatic and symptomatic phase of the Mdr1a knockout model of spontaneous colitis. Soluble BTNL2-Fc protein inhibits proliferation of murine T4 cells from the spleen, mesenteric lymph node, and Peyer's patch.

BTNL2 Antigen Profile

Protein Summary

Negative regulator of T-cell proliferation.

Gene names and symbols associated with BTNL2

  • butyrophilin like 2 (BTNL2) antibody
  • butyrophilin-like 2 (Btnl2) antibody
  • butyrophilin-like 2 (MHC class II associated) (BTNL2) antibody
  • butyrophilin-like protein 2 (LOC100348151) antibody
  • BTL-II antibody
  • Btl2 antibody
  • BTLN2 antibody
  • BTNL2 antibody
  • Gm315 antibody
  • HSBLMHC1 antibody
  • NG9 antibody
  • SS2 antibody

Protein level used designations for BTNL2

butyrophilin-like protein 2 , butyrophylin-like MHC class II associated , butyrophilin-like 2 (MHC class II associated) , butyrophilin-like protein 2-like

56244 Homo sapiens
309620 Rattus norvegicus
481730 Canis lupus familiaris
547431 Mus musculus
745506 Pan troglodytes
789224 Bos taurus
100051881 Equus caballus
100348151 Oryctolagus cuniculus
100441854 Pongo abelii
100158014 Sus scrofa
Selected quality suppliers for anti-BTNL2 (BTNL2) Antibodies
Did you look for something else?